122 related articles for article (PubMed ID: 16761109)
1. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents.
Vrana JA; Cleaveland ES; Eastman A; Craig RW
Apoptosis; 2006 Aug; 11(8):1275-88. PubMed ID: 16761109
[TBL] [Abstract][Full Text] [Related]
2. Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C.
Townsend KJ; Trusty JL; Traupman MA; Eastman A; Craig RW
Oncogene; 1998 Sep; 17(10):1223-34. PubMed ID: 9771965
[TBL] [Abstract][Full Text] [Related]
3. MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.
Domina AM; Vrana JA; Gregory MA; Hann SR; Craig RW
Oncogene; 2004 Jul; 23(31):5301-15. PubMed ID: 15241487
[TBL] [Abstract][Full Text] [Related]
4. Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.
Domina AM; Smith JH; Craig RW
J Biol Chem; 2000 Jul; 275(28):21688-94. PubMed ID: 10777489
[TBL] [Abstract][Full Text] [Related]
5. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.
Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS
J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799
[TBL] [Abstract][Full Text] [Related]
6. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
7. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
Kozopas KM; Yang T; Buchan HL; Zhou P; Craig RW
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3516-20. PubMed ID: 7682708
[TBL] [Abstract][Full Text] [Related]
8. Induction of BCL2 family member MCL1 as an early response to DNA damage.
Zhan Q; Bieszczad CK; Bae I; Fornace AJ; Craig RW
Oncogene; 1997 Mar; 14(9):1031-9. PubMed ID: 9070651
[TBL] [Abstract][Full Text] [Related]
9. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation.
Townsend KJ; Zhou P; Qian L; Bieszczad CK; Lowrey CH; Yen A; Craig RW
J Biol Chem; 1999 Jan; 274(3):1801-13. PubMed ID: 9880563
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor.
Katoh O; Takahashi T; Oguri T; Kuramoto K; Mihara K; Kobayashi M; Hirata S; Watanabe H
Cancer Res; 1998 Dec; 58(23):5565-9. PubMed ID: 9850095
[TBL] [Abstract][Full Text] [Related]
11. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
Lee YC; Chen YJ; Huang CH; Chang LS
Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735
[TBL] [Abstract][Full Text] [Related]
12. An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine.
Vrana JA; Bieszczad CK; Cleaveland ES; Ma Y; Park JP; Mohandas TK; Craig RW
Cancer Res; 2002 Feb; 62(3):892-900. PubMed ID: 11830549
[TBL] [Abstract][Full Text] [Related]
13. Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression.
Changchien JJ; Chen YJ; Huang CH; Cheng TL; Lin SR; Chang LS
Toxicol Appl Pharmacol; 2015 Apr; 284(1):33-41. PubMed ID: 25684043
[TBL] [Abstract][Full Text] [Related]
14. Inactive caspase 3 activates Akt in human leukemia cells susceptible or resistant to apoptosis induced by phorbol ester.
Hah JO; Lee KA; Choi YJ; Kim WD; Park JW; Kwon TK
Int J Oncol; 2003 May; 22(5):1111-6. PubMed ID: 12684678
[TBL] [Abstract][Full Text] [Related]
15. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
16. BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells.
Chiou JT; Wu YY; Lee YC; Chang LS
Biochem Pharmacol; 2023 Sep; 215():115738. PubMed ID: 37562509
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells.
Ito Y; Mishra NC; Yoshida K; Kharbanda S; Saxena S; Kufe D
Cell Death Differ; 2001 Aug; 8(8):794-800. PubMed ID: 11526432
[TBL] [Abstract][Full Text] [Related]
18. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression.
Chiou JT; Chang LS
Apoptosis; 2024 Apr; 29(3-4):503-520. PubMed ID: 38066391
[TBL] [Abstract][Full Text] [Related]
19. Albendazole-Induced SIRT3 Upregulation Protects Human Leukemia K562 Cells from the Cytotoxicity of MCL1 Suppression.
Wang LJ; Liou LR; Shi YJ; Chiou JT; Lee YC; Huang CH; Huang PW; Chang LS
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486166
[TBL] [Abstract][Full Text] [Related]
20. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells.
Matsumoto E; Hatanaka M; Bohgaki M; Maeda S
Kobe J Med Sci; 2006; 52(6):181-94. PubMed ID: 17329956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
